The advertisement promotes RESULTI as the first and only FDA-approved treatment for agitation associated with dementia due to Alzheimer's disease, while also providing important safety warnings regarding increased mortality in elderly patients with dementia-related psychosis.
Creative Information
| CID: | 8e89ecc0-f9aa-4ae3-bc94-a2685e2448cf |
| CRID: | 82_6121-935083 |
| Domain: | rexultihcp.com |
| Seat: | PP |
| Size: | 728x90 |
| Bid: | $0.31 |
| Timestamp: | 12/22/2025, 5:33:27 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 12/22/2025, 5:33:58 PM | 6.23s | |
| adomain_analysis | success | 12/22/2025, 5:33:56 PM | 2.85s | |
| adomain_capture | success | 12/22/2025, 5:33:53 PM | 0.11s | |
| ad_render | success | 12/22/2025, 5:33:52 PM | 24.12s | |
| brand_mapping | success | 12/22/2025, 5:33:55 PM | 1.53s | |
Analysis Results
Ad Format: banner
Brands: Rexulti
Sensitive:Misleading Health ClaimsUnverified Medical TreatmentsPharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1467.02 KB | ||||||||||||||||||||||
| Render Time: | 8.48 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1467.15 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


